stockrow
Friday 6 November 2026
Export RVPH’s income statement to Excel — free account
Reviva Pharmaceuticals Holdings, Inc.
RVPH Healthcare Biotechnology
- EPS
- +92.1%
- Free cash flow
- +57.8%
Quarter to June 2026, against a year earlier
0.37
0.03
+8.82%
Follow RVPH
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
1.39 | 2.08 | 3.85 | 3.56 |
Net Debt/EBITDA |
3.27 | 4.06 | 6.78 | 7.60 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.39 | 1.72 | 1.19 | 0.86 | |
Interest Coverage |
(1,549.92) | 635.54 | (488.36) | (902.59) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(1.54) | (1.60) | (0.54) | (0.16) | |
Cash per Share |
3.63 | 3.98 | 3.16 | 1.51 | |
Shareholders Equity per Share |
1.25 | 2.38 | 2.48 | 1.15 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.25 | 2.38 | 2.48 | 1.15 | |
Free Cash Flow |
(5.59) | (5.80) | (3.80) | (2.12) | |
Working Capital |
3.77 | 7.83 | 17.44 | 15.21 | |
Net Current Asset Value |
3.73 | 7.83 | 17.44 | 15.21 | |
| Other line items | |||||
Quick Ratio |
1.35 | 1.98 | 3.63 | 3.35 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.54) | (1.60) | (0.54) | (0.16) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
7.10 | 4.65 | 3.40 | 3.71 | |
Average Assets |
10.98 | 15.71 | 15.32 | 16.39 | |
Average Common Equity |
(2.72) | 4.73 | 6.49 | 7.37 |
Columns are period end dates · fundamentals updated 2 Nov 2026